These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6135325)

  • 41. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
    Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
    Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
    Mayer AM
    Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of phospholipase A2 by protein I.
    Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
    Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid.
    Vallee E; Gougat J; Ageron M
    Agents Actions; 1980 Apr; 10(1 Pt 2):57-62. PubMed ID: 7386309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deficiency of vitamin E and selenium enhances calcium-independent phospholipase A2 activity in rat lung and liver.
    Kuo CF; Cheng S; Burgess JR
    J Nutr; 1995 Jun; 125(6):1419-29. PubMed ID: 7782894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An examination of the involvement of phospholipases A2 and C in the alpha-adrenergic and gamma-aminobutyric acid receptor modulation of cyclic AMP accumulation in rat brain slices.
    Duman RS; Karbon EW; Harrington C; Enna SJ
    J Neurochem; 1986 Sep; 47(3):800-10. PubMed ID: 2874192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effect of FO-1561 (S-adenosyl-L-methionine sulfate tosylate) on phospholipase A2.
    Ishikawa Y; Kanzaki T; Morisaki N; Saito Y; Yoshida S
    Tohoku J Exp Med; 1987 Nov; 153(3):211-5. PubMed ID: 3433277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism.
    Fischer SM; Mills GD; Slaga TJ
    Carcinogenesis; 1982; 3(11):1243-5. PubMed ID: 7151243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uteroglobin inhibits phospholipase A2 activity.
    Levin SW; Butler JD; Schumacher UK; Wightman PD; Mukherjee AB
    Life Sci; 1986 May; 38(20):1813-9. PubMed ID: 3084897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine inhibits phenylephrine activation of phospholipase A in hamster brown adipocytes.
    Schimmel RJ; Elliott ME
    Biochem Biophys Res Commun; 1988 Apr; 152(2):886-92. PubMed ID: 3130056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E; Gougat J; Navarro J; Delahayes JF
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Stasi M; Pistolesi R; Nenci GG; Goracci G
    Agents Actions; 1990 Mar; 29(3-4):364-73. PubMed ID: 2111085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oligomers of prostaglandin B1 inhibit in vitro phospholipase A2 activity.
    Franson RC; Rosenthal MD
    Biochim Biophys Acta; 1989 Dec; 1006(3):272-7. PubMed ID: 2597672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Permissive stimulation of Ca(2+)-induced phospholipase A2 by an adenosine receptor agonist in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells: a new 'cross-talk' mechanism in Ca2+ signalling.
    Shimegi S; Okajima F; Kondo Y
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):845-51. PubMed ID: 8192675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of a method for the study of drugs which inhibit phospholipase A2].
    Alcaraz MJ
    Arch Farmacol Toxicol; 1985 Aug; 11(2):73-8. PubMed ID: 3002289
    [No Abstract]   [Full Text] [Related]  

  • 57. Are phospholipid-binding proteins in vivo phospholipase inhibitors?
    Poensgen J
    Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells.
    Rothhut B; Comera C; Prieur B; Errasfa M; Minassian G; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):169-75. PubMed ID: 2954855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
    Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
    Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Nakadate T; Yamamoto S; Iseki H; Sonoda S; Takemura S; Ura A; Hosoda Y; Kato R
    Gan; 1982 Dec; 73(6):841-3. PubMed ID: 6819174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.